ask="3.77"
ask_size="500"
average_daily_volume="41115"
bid="1.00"
bid_size="200"
book_value="-0.93"
change="+0.05"
change_from_200_day_moving_average="-0.44"
change_from_50_day_moving_average="-0.03"
change_from_52_week_high="-2.29"
change_From_52_week_low="1.40"
change_in_percent="+1.59%"
close="3.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.26"
ebitda="-50.77M"
eps_estimate_current_year="-1.26"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.48"
ex_dividend_date="N/A"
float_shares="10398000"
high="3.20"
high_52_weeks="5.49"
last_trade_date="3/2/2017"
last_trade_price="3.20"
last_trade_size="100"
last_trade_time="3:59pm"
low="3.11"
low_52_weeks="1.80"
market_capitalization="75.62M"
moving_average_200_day="3.64"
moving_average_50_day="3.23"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.00"
open="3.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-12.10%"
percent_change_from_50_day_moving_average="-0.98%"
percent_change_from_52_week_high="-41.71%"
percent_change_from_52_week_low="+77.39%"
previous_close="3.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="32.54"
revenue="2.29M"
shares_outstanding="23631000"
short_ratio="1.11"
stock_exchange="NGM"
symbol="ONS"
volume="12313"
weeks_range_52="1.80 - 5.49"
